Raymond James & Associates’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $217K | Buy |
4,107
+234
| +6% | +$12.4K | ﹤0.01% | 3569 |
|
|
2024
Q2 | $210K | Sell |
3,873
-4,031
| -51% | -$218K | ﹤0.01% | 3546 |
|
|
2024
Q1 | $554K | Sell |
7,904
-6,923
| -47% | -$485K | ﹤0.01% | 2984 |
|
|
2023
Q4 | $1.24M | Sell |
14,827
-1,861
| -11% | -$155K | ﹤0.01% | 2382 |
|
|
2023
Q3 | $492K | Sell |
16,688
-219
| -1% | -$6.45K | ﹤0.01% | 2887 |
|
|
2023
Q2 | $552K | Sell |
16,907
-512
| -3% | -$16.7K | ﹤0.01% | 2858 |
|
|
2023
Q1 | $613K | Buy |
17,419
+11
| +0.1% | +$387 | ﹤0.01% | 2774 |
|
|
2022
Q4 | $798K | Buy |
17,408
+2,752
| +19% | +$126K | ﹤0.01% | 2558 |
|
|
2022
Q3 | $710K | Sell |
14,656
-1,025
| -7% | -$49.7K | ﹤0.01% | 2598 |
|
|
2022
Q2 | $616K | Buy |
15,681
+360
| +2% | +$14.1K | ﹤0.01% | 2766 |
|
|
2022
Q1 | $564K | Buy |
+15,321
| New | +$564K | ﹤0.01% | 2988 |
|
|
2020
Q4 | – | Sell |
-9,784
| Closed | -$212K | – | 3634 |
|
|
2020
Q3 | $212K | Buy |
+9,784
| New | +$212K | ﹤0.01% | 3152 |
|
|
2016
Q4 | – | Sell |
-11,450
| Closed | -$105K | – | 3102 |
|
|
2016
Q3 | $105K | Sell |
11,450
-1,000
| -8% | -$9.17K | ﹤0.01% | 2946 |
|
|
2016
Q2 | $118K | Sell |
12,450
-166
| -1% | -$1.57K | ﹤0.01% | 2755 |
|
|
2016
Q1 | $89K | Buy |
+12,616
| New | +$89K | ﹤0.01% | 2708 |
|